Form 4 for IQV IQVIA
Accepted 2025-12-19 00:00:00 ET · period of report 2025-12-18 · accession 0001628280-25-058339 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-19 | 2025-12-18 | IQV | BOUSBIB ARI | See Remarks, Dir | M - OptEx | $59.90 | +50.0K | 857.2K | +6% | +$3.00M |
| D | 2025-12-19 | 2025-12-18 | IQV | BOUSBIB ARI | See Remarks, Dir | S - Sale+OE | $222.43 | -36.6K | 820.6K | -4% | -$8.13M |
| D | 2025-12-19 | 2025-12-18 | IQV | BOUSBIB ARI | See Remarks, Dir | D - Sale to Iss | $222.91 | -13.4K | 807.2K | -2% | -$3.00M |
| D | 2025-12-19 | 2025-12-18 | IQV | BOUSBIB ARI | See Remarks, Dir | M - OptEx | $59.90 | -50.0K | 0 | -100% | -$3.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-18 | M | A | 50,000 | $59.90 | 857,163 | D | — | — | (F1) Represents the exercise of stock appreciation rights expiring on February 2, 2026. |
| 2 | Common | Common Stock | 2025-12-18 | S | D | 36,564 | $222.43 | 820,599 | D | — | — | (F1) Represents the exercise of stock appreciation rights expiring on February 2, 2026. (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.28 to $222.79, inclusive. |
| 3 | Common | Common Stock | 2025-12-18 | D | D | 13,436 | $222.91 | 807,163 | D | — | — | (F1) Represents the exercise of stock appreciation rights expiring on February 2, 2026. |
| 4 | Derivative | Stock Appreciation Right | 2025-12-18 | M | D | 50,000 | $59.90 | 0 | D | $59.90 · 2020-02-02 to 2026-02-02 | 50,000 Common Stock |